Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
European Cytokine Network|December 15, 2018
Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's diseaseArezki Chekaoui, Karima Lahmar, Houda Belguendouz, et al.Journal of Inflammation (London, England)|November 23, 2011
Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's diseaseDjamel Messaoudene, Houda Belguendouz, Mohamed Laid Ahmedi, et al.International Immunopharmacology|January 14, 2020
Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor AllopurinolArezki Chekaoui, Houda Belguendouz, Karima Lahmar, et al.International Immunopharmacology|October 3, 2021
In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet diseaseNourelhouda Ghozali, Houda Belguendouz, Djamel Messaoudene, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|May 13, 2022
Increased Salivary Cytokines and Nitric Oxide Levels in Behçet's Disease: Interleukin-32, a Novel Player in Disease PrognosisZohra Hadjimi, Houda Belguendouz, Sarah Benchabane, et al.Immunology Letters|May 17, 2026
Elevated cytokine and nitric oxide levels in Behçet disease: EBI-3 as a potential biomarker of vascular involvementNourelhouda Ghozali, Zohra Hadjimi, Zahira Abdesselam, et al.Clinicoeconomics and Outcomes Research : CEOR|October 22, 2019
Management Of Glaucoma In Developing Countries: Challenges And Opportunities For ImprovementMaria Fernanda Delgado, Ahmed Mostafa Abdelrahman, Malika Terahi, et al.Pageof 1